Results 271 to 280 of about 167,795 (308)
Some of the next articles are maybe not open access.
Combined modality therapy for rectal and colon cancer
Seminars in Oncology, 2003Combined modality therapy (CMT) with radiation therapy and chemotherapy plays an important role in the management of rectal cancer. Postoperatively, pelvic irradiation and 5-fluorouracil-based chemotherapy have been used to improve local control and survival for high-risk patients after local excision, as well as for patients undergoing ...
Ashish K, Chawla +3 more
openaire +2 more sources
Taxanes in Combined Modality Therapy
2003The taxanes are a relatively new group of plant-derived chemotherapeutic agents that have been studied quite extensively in both preclinical studies and in clinical trials. This group of drugs, which includes paclitaxel (Taxol) and docetaxel (Taxotere), act as mitotic spindle inhibitors through their promotion of microtubule assembly and retardation of
Robert M. MacRae, Hak Choy
openaire +1 more source
Adjuvant combined modality therapy for malignant meningiomas
Journal of Neurosurgery, 1996✓ Malignant meningiomas constitute 10% to 15% of all meningiomas and limited information exists regarding adjuvant treatment of these aggressive primary brain tumors. Fourteen patients (eight men, six women), ranging in age from 28 to 61 years (median 51 years), were prospectively treated for primary malignant meningiomas according to an institutional ...
openaire +2 more sources
Combined-Modality Therapy of Cancer
New England Journal of Medicine, 1985The three major methods of treatment for cancer are surgery, irradiation, and chemotherapy. Each has been shown to have considerable efficacy in the therapy of selected cancers, and each has its ow...
openaire +2 more sources
Combined modality therapy in NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology, 2001Combined modality treatment has 'come out of age' and increasingly represents standard of care for a rapidly growing number of patients in locally advanced stages of NSCLC. Modern progress of treatment techniques as well as possibilities for supportive interventions will lead to lesser treatment toxicities, better patient's compliance to treatment ...
W, Eberhardt, S, Bildat, S, Korfee
openaire +1 more source
Cancer of the Gastroesophageal Junction: Combined Modality Therapy
Surgical Oncology Clinics of North America, 2006Esophageal cancer, an uncommon, but highly virulent malignancy in the United States, will be responsible for nearly 14,000 deaths in the year 2005. The prognosis for patients who have adenocarcinoma of the distal esophagus and gastroesophageal junction and who are treated with the standard approaches of surgery or combined chemoradiation therapy is ...
openaire +2 more sources
Optimizing combined modality therapy for Hodgkin’s disease
International Journal of Radiation Oncology*Biology*Physics, 2003cured of their Hodgkin’s disease. Of the 20%–25% who do relapse, the majority of these are cured with subsequent salvage programs employing either chemotherapy alone or combined modality therapy. The problem, of course, is what happens beyond 10 years. Patients treated with full-dose subtotal nodal radiotherapy, i.e., doses in the range of 40 Gy, will ...
openaire +2 more sources
Combining radiation therapy with other treatment modalities.
Seminars in veterinary medicine and surgery (small animal), 1995Combining treatment modalities is indicated when single modality treatment does not result in adequate tumor control, or if the cosmetic or functional outcome of single modality treatment is less than desirable. The combination of surgery and radiation has proven useful in the treatment of both human and veterinary patients.
LARUE, SM, VUJASKOVIC, Z
openaire +2 more sources
Future of combined modality therapy
International Journal of Radiation Oncology*Biology*Physics, 1981openaire +2 more sources